Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -636.99% is in line with its 1-year average of -638.58%, around the middle of its 1-year range (-1065.17%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1065.17%.
NET PROFIT MARGIN
-636.99%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 622 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Generate Biomedicines, Inc.
Market Cap
$1.76B
Net Profit Margin
-636.99%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.73B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.72B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.72B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.81B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$1.82B
Net Profit Margin
-21.25%
TTM Avg
-24.32%
3Y Avg
-26.63%
5Y Avg
-18.90%
Market Cap
$1.82B
Net Profit Margin
25.02%
TTM Avg
21.58%
3Y Avg
17.87%
5Y Avg
17.55%
Market Cap
$1.84B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.64B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.76B | -636.99% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -14.99% | -20.12% | -16.95% | -10.04% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | 0.89% | -2.38% | -5.83% | -7.07% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | -672.16% | -753.31% | -935.73% | -797.48% |
| Absci Corporation (ABSI)vs › | $1.81B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Novocure Ltd (NVCR)vs › | $1.82B | -21.25% | -24.32% | -26.63% | -18.90% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 25.02% | 21.58% | 17.87% | 17.55% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.05% | 1.42% | 2.79% | 2.28% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | -13.50% | -22.64% | -31.77% | -40.07% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -59.87% | 5.85% | -31.86% | -479.70% |
Operating Margin
-737.0%
Net Profit Margin
-637.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1065.17% |
| 2026-03-31 | -850.58% |
| 2025-12-31 | 0.00% |
